EGLE THERAPEUTICS
Egle Therapeutics is an emerging biotechnology company focused on developing First-In-Class immunotherapies targeting immune suppressor regulatory T-cells (Tregs) for oncology and autoimmune diseases. The company was founded in 2020 and is based in Paris, France.
EGLE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2020-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.egle-tx.com
Total Employee:
11+
Status:
Active
Contact:
+33-186640857
Email Addresses:
[email protected]
Total Funding:
40 M EUR
Technology used in webpage:
Microsoft Exchange Online
Similar Organizations
Immunscape AB
Immunscape is a privately held drug discovery focused on developing immunotherapies for cancer and autoimmune disease treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
Fund+
Fund+ investment in Series A - Egle Therapeutics
Takeda Ventures
Takeda Ventures investment in Series A - Egle Therapeutics
Life Sciences Partners
Life Sciences Partners investment in Series A - Egle Therapeutics
Bpifrance
Bpifrance investment in Series A - Egle Therapeutics
Bioqube Ventures
Bioqube Ventures investment in Series A - Egle Therapeutics
Official Site Inspections
http://www.egle-tx.com
- Host name: cluster020.hosting.ovh.net
- IP address: 46.105.57.169
- Location: Saint-Ouen France
- Latitude: 48.9067
- Longitude: 2.3339
- Timezone: Europe/Paris
- Postal: 93400
More informations about "Egle Therapeutics"
egle - Modulating Treg Cells to Balance Immunity
He is also President of Flanders.bio the organization of biotech companies in Flanders. Elisa El Nouchi. Associate at BPI-Innobio2. Elisa El Nouchi is an Associate in the Life Sciences …See details»
Egle Therapeutics - Crunchbase Company Profile
Oct 22, 2021 Contact Email [email protected] Phone Number +33-186640857 Egle Therapeutics is an emerging biotechnology company focused on developing First-In-Class immunotherapies targeting immune suppressor …See details»
Egle Therapeutics - LinkedIn
Egle Therapeutics is thrilled to announce its upcoming participation to the Society for Immunotherapy of Cancer (SITC) in Houston from Nov 6 to 10. Do not miss the opportunity to meet with our # ...See details»
Egle - Overview, News & Similar companies | ZoomInfo.com
May 9, 2024 Egle contact info: Phone number: +33 186640857 Website: www.egle-tx.com What does Egle do? Egle, a biotechnology company that focuses on developing immunotherapies …See details»
Egle Therapeutics - EQT Group
Nov 22, 2024 egle-tx.com. Sector. Healthcare. Country. France. Fund. LSP 7. Entry. 2021. Web. egle-tx.com. Latest news. 29 November 2024 EQT Exeter completes Spanish student housing portfolio sale to Azora; 26 November …See details»
Egle Therapeutics Management Team | Org Chart - RocketReach
Egle Therapeutics employs 33 employees. The Egle Therapeutics management team includes Luc Boblet (Founder and CEO), Pierre ... egle-tx.com; 3 267546XXXX; 610647XXXX; …See details»
Egle Therapeutics - VentureRadar
Mar 2, 2021 Egle Therapeutics has assembled a proprietary translational based target discovery engine leveraging patient samples to map out - at the single cell level - unique transcriptomic …See details»
EGLE Therapeutics Strengthens its Board of Directors with the ...
Paris, France – September 12, 2024 . PARIS–(BUSINESS WIRE)– EGLE Therapeutics, a clinical-stage biotechnology company uniquely positioned to advance the next generation of …See details»
Egle - Ownership and Business Overview - Mergr
Www.egle-tx.com. Profile Investors (1) ... Egle is a biotechnology company focused on developing first in class T-regulatory cell therapies based on Treg-starvers for oncology and autoimmune …See details»
Egle Therapeutics SAS - Drug pipelines, Patents, Clinical trials
Egle is evaluating its most advanced drug candidate in oncology, EGL-001 (a Treg-selective anti-CTLA4-IL-2m), in a Phase I/II clinical trial. In auto-immunity, Egle aspires to advance toward …See details»
EGL-001 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 29, 2024 Egle is evaluating its most advanced drug candidate in oncology, EGL-001 (a Treg-selective anti-CTLA4-IL-2m), in a Phase I/II clinical trial. In auto-immunity, Egle aspires to …See details»
Egle Therapeutics Company Information - Funding, Investors, and …
Egle Therapeutics, based in Paris, is developing advanced immunotherapies for cancer and autoimmune diseases. Unlike traditional treatments, which often have severe side effects and …See details»
Egle Therapeutics - EU-Startups
Egle Therapeutics is an emerging biotechnology company focused on developing First-In-Class immunotherapies targeting immune suppressor regulatory T-cells (Tregs) for oncology and …See details»
EGL-003 - Drug Targets, Indications, Patents - Synapse
Nov 21, 2024 Egle is evaluating its most advanced drug candidate in oncology, EGL-001 (a Treg-selective anti-CTLA4-IL-2m), in a Phase I/II clinical trial. In auto-immunity, Egle aspires to …See details»
Egle Therapeutics raises 40 million € Series A to develop First-In ...
Egle Therapeutics SAS (Egle), an emerging biotechnology company focused on developing First-In- Class immunotherapies targeting immune suppressor regulatory T-cells (Tregs) for …See details»
New Fund+ portfolio company ! Egle Tx raises 40 million - LinkedIn
Oct 22, 2021 The key element of Egle’s core approach is the leveraging of itstranslational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed ...See details»
Egle Therapeutics to Share Preclinical Efficacy Data for EGL-001, a ...
Oct 25, 2024 Egle is leveraging a proprietary discovery platform to unveil novel Treg specific targets and to develop innovative Treg-focused drug candidates for oncology and autoimmune …See details»
Egle Therapeutics (France) Funding: €40M - medicalstartups.org
Nov 7, 2024 Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune...See details»
More documents for Egle Therapeutics SAS - Life-Sciences …
Upcoming Events. Stifel Biotech Summer Summit 2024 Newport, RI; Canaccord Genuity Annual Growth Conference 2024 Boston; Wedbush PacGrow Healthcare Conference 2024 New YorkSee details»
Marilyn N Egle, 96 - Edinburg, TX - Reputation & Contact Details
Marilyn Egle is 96 years old today because Marilyn's birthday is on 07/27/1928. Before moving to Marilyn's current city of Edinburg, TX, Marilyn lived in McAllen TX. Other names that Marilyn …See details»